| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Company Achieves Third Consecutive Quarter of Revenue GrowthRevenue Increase of Approximately 32% Sequentially and 28% Year-Ove...
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening SystemINBS anticipates...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering...
Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.36) per share. The company reported $843.884 thousand...